The Effect of Transcatheter Mitral Valve Repair on Short-Term Mortality in Patients With Chronic Kidney Disease - A Systematic Review and Meta-Analysis.
Chronic kidney disease
Interventional cardiology
Structural cardiology
Transcatheter mitral valve repair
Journal
Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
30
04
2020
revised:
05
09
2020
accepted:
23
09
2020
pubmed:
4
11
2020
medline:
25
2
2023
entrez:
3
11
2020
Statut:
ppublish
Résumé
Transcatheter Mitral Valve Repair (TMVr) offers clinically significant benefit to select symptomatic patients with severe mitral regurgitation (MR). We conducted a systematic review and meta-analysis of clinical trials and observational studies to identify the effect of pre-procedural Chronic Kidney disease (CKD) on short-term mortality in TMVr. We found CKD is a predictor of 30-day mortality in patients undergoing TMVr. Specifically, a GFR < 30 mL/min conveys a significant increase in 30-day mortality. This is significant for patient selection, prognostication, as well as identifies an area of need for further research. SUMMARY FOR ANNOTATED TABLE OF CONTENTS: A systematic review and meta-analysis looking at short-term mortality in patients undergoing Transcatheter Mitral Valve Repair with chronic kidney disease. Findings show severe renal disease is associated with increased 30-day mortality.
Identifiants
pubmed: 33139220
pii: S1553-8389(20)30587-X
doi: 10.1016/j.carrev.2020.09.035
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
78-84Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no conflicts of interest to disclose.